Ally Bridge Group (Ny) LLC Tyra Biosciences, Inc. Transaction History
Ally Bridge Group (Ny) LLC
- $76.1 Million
- Q1 2025
A detailed history of Ally Bridge Group (Ny) LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 107,244 shares of TYRA stock, worth $1.04 Million. This represents 1.31% of its overall portfolio holdings.
Number of Shares
107,244
Previous 175,063
38.74%
Holding current value
$1.04 Million
Previous $2.43 Million
59.02%
% of portfolio
1.31%
Previous 2.76%
Shares
4 transactions
Others Institutions Holding TYRA
# of Institutions
119Shares Held
55.5MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$104 Million2.05% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.14MShares$40.3 Million95.26% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$39.7 Million90.83% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$39.5 Million8.77% of portfolio
-
Nextech Invest Ag4.06MShares$39.5 Million10.51% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $408M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...